The core activity of AdRegeneer AG is the development of regenerative medicines for the nervous system, particularly for the treatment of multiple sclerosis and spinal cord injuries.
AI-generated
Comparisons
AdRegeneer AG in comparison
Soon
Industry comparisons are coming soon
We're preparing industry comparisons that rank AdRegeneer AG by reviews, experience and specialisations.
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.